MDL | MFCD00036236 |
---|---|
Molecular Weight | 470.68 |
Molecular Formula | C27H50O6 |
SMILES | CCCCCCCC(OCC(OC(CCCCCCC)=O)COC(CCCCCCC)=O)=O |
Human Endogenous Metabolite |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT02602158 | University of Zurich |
Healthy
|
October 2015 | Early Phase 1 |
NCT04268953 | Cerecin |
Alzheimer Disease
|
February 27, 2020 | Phase 1 |
NCT00142805 | Cerecin |
Alzheimer´s Disease
|
November 4, 2004 | Phase 2 |
NCT04727970 | Cerecin |
Infantile Spasm
|
November 1, 2021 | Phase 1 |
NCT04187547 | Cerecin |
Alzheimer´s Disease
|
June 30, 2022 | Phase 3 |
NCT00355550 | Cerecin |
Age-Associated Memory Impairment
|
July 2006 | Phase 2 |
NCT03971123 | Cerecin |
Alzheimer Disease
|
August 30, 2019 | Phase 1 |
NCT04437199 | Cerecin |
Migraine
|
December 17, 2020 | Phase 2 |
NCT03628352 | Cerecin |
Taste Profile Assessments
|
September 10, 2018 | Phase 1 |
NCT03551769 | Cerecin |
Alzheimer Disease
|
August 5, 2018 | Phase 1 |
Liquid
Room temperature in continental US; may vary elsewhere.
Pure form | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 41.67 mg/mL ( 88.53 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.1246 mL | 10.6229 mL | 21.2459 mL |
5 mM | 0.4249 mL | 2.1246 mL | 4.2492 mL |
10 mM | 0.2125 mL | 1.0623 mL | 2.1246 mL |